As of Dec. 18, 2023, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in individuals aged 9 years and older.
First Wave BioPharma Inc (NASDAQ: FWBI) has signed a non-binding term sheet to acquire ImmunogenX in an all-stock transaction with the combined company focused on advancing a pipeline for gastrointestinal (GI) diseases.
U.S. stock futures were higher this morning, with the Dow Jones futures gaining over 75 points on Monday.
Here are some big stocks recording losses in today’s pre-market trading session.
The CNN Money Fear and Greed index showed a decline in overall market sentiment, but the index remained in the "Greed" zone on Friday.
The Dow Jones index closed higher on Friday, with all three major indices recording gains for the seventh straight week.